CELSENTRI Side Effects

6976877-2 | Bone Marrow Failure, Diarrhoea, Lung Disorder, Nausea, Pancytopenia, Pyrexia, Respiratory Distress
on Sep 03, 2010 Female patient from FRANCE , weighting 85.98 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Celsentri (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, diarrhoea, lung disorder, nausea (What is nausea?), pancytopenia, pyrexia, respiratory distress. Celsentri dosage: 300mg Twice Per Day. During the same period patient was treated with METHOTREXATE (4500mg Every 3 Weeks) (View Methotrexate Review and Methotrexate Label ), ARACYTINE (2600mg Every 3 Weeks) (View Aracytine Review and Aracytine Label ), ISENTRESS (View Isentress Review and Isentress Label ), INTELENCE (View Intelence Review and Intelence Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ). Patient was hospitalized.

6857142-0 | Hepatic Enzyme Increased
Patient was taking Celsentri (View Usage). Patient had the following side effects: hepatic enzyme increased on Jul 12, 2010 from GERMANY Additional patient health information: Male patient , 50 years of age, weighting 174.2 lb, was diagnosed with hiv infection (What is hiv infection?) and. Celsentri dosage: 300mg Twice Per Day. During the same period patient was treated with VIRAMUNE (200mg Twice Per Day) (View Viramune Review and Viramune Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ), ISENTRESS (400mg Twice Per Day) (View Isentress Review and Isentress Label ), RETROVIR (250mg Twice Per Day) (View Retrovir Review and Retrovir Label ).

6674724-X | Cachexia, Enanthema, Escherichia Sepsis, Gastroenteritis Cryptosporidial, Hypoproteinaemia, Mycobacterium Avium Complex Infection, Oedema, Psychotic Disorder
Adverse event was reported on Mar 29, 2010 by a Male patient taking Celsentri (View Usage) (Dosage: Unk) was diagnosed with acquired immunodeficiency syndrome and. Location: CANADA , 37 years of age, After Celsentri was administered, patient had the following side effects: cachexia, enanthema, escherichia sepsis, gastroenteritis cryptosporidial, hypoproteinaemia, mycobacterium avium complex infection, oedema, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with TRUVADA (Unk) (View Truvada Review and Truvada Label ), RALTEGRAVIR (Unk) (View Raltegravir Review and Raltegravir Label ), ZITHROMAX (Unk) (View Zithromax Review and Zithromax Label ), ETHAMBUTOL (Unk) (View Ethambutol Review and Ethambutol Label ), RIFABUTIN (Unk) (View Rifabutin Review and Rifabutin Label ), RIFAMPIN (Unk) (View Rifampin Review and Rifampin Label ). Patient was hospitalized.

6663497-2 | Angioedema, Rash, Respiratory Disorder
on Mar 22, 2010 Male patient from SPAIN , 16 years of age, weighting 130.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Celsentri (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, rash (What is rash?), respiratory disorder. Celsentri dosage: 600 Mg, 2x/day. During the same period patient was treated with ETRAVIRINE (Unk) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (Unk) (View Raltegravir Review and Raltegravir Label ). Patient was hospitalized.


6503495-2 | Supraventricular Extrasystoles, Vision Blurred, Visual Acuity Reduced
on Dec 07, 2009 Male patient from GERMANY , 45 years of age, was diagnosed with hiv infection (What is hiv infection?), atrial fibrillation (What is atrial fibrillation?) and was treated with Celsentri (View Usage). Patient had the following side effects: supraventricular extrasystoles, vision blurred, visual acuity reduced. Celsentri dosage: 300 Mg, 2x/day. During the same period patient was treated with TRUVADA (Unk) (View Truvada Review and Truvada Label ), METOPROLOL (95 Mg, 1x/day) (View Metoprolol Review and Metoprolol Label ), KALIUM (Unk) (View Kalium Review and Kalium Label ), MAGNESIUM (Unk) (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

6441845-6 | Asthenia, Body Temperature Increased, Bronchitis, Herpes Zoster, Infection Susceptibility Increased, Urinary Tract Infection
Patient was taking Celsentri (View Usage). After Celsentri was administered, patient had the following side effects: asthenia, body temperature increased, bronchitis (What is bronchitis?), herpes zoster, infection susceptibility increased, urinary tract infection (What is urinary tract infection?) on Nov 04, 2009 from GERMANY Additional patient health information: Male patient , 35 years of age, weighting 165.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Celsentri dosage: 150 Mg, 1x/day. During the same period patient was treated with ATAZANAVIR (300 Mg, 1x/day) (View Atazanavir Review and Atazanavir Label ), NORVIR (100 Mg, 1x/day) (View Norvir Review and Norvir Label ).

6414181-1 | Gallbladder Disorder, Gastroenteritis
Adverse event was reported on Oct 14, 2009 by a Female patient taking Celsentri (View Usage) (Dosage: 150 Mg, 2x/day) was diagnosed with hiv infection (What is hiv infection?), herpes simplex (What is herpes simplex?), gastroenteritis (What is gastroenteritis?) and. Location: AUSTRALIA , 46 years of age, Patient experienced the following unwanted or unexpected effects: gallbladder disorder, gastroenteritis (What is gastroenteritis?). During the same period patient was treated with ATAZANAVIR (300 Mg, 1x/day) (View Atazanavir Review and Atazanavir Label ), RITONAVIR (100 Mg, 1x/day) (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (1000 Mg, 2x/day) (View Saquinavir Review and Saquinavir Label ), TRUVADA (Unk) (View Truvada Review and Truvada Label ), VALTREX (500 Mg, 1x/day) (View Valtrex Review and Valtrex Label ), REPALYTE (1 Unk, 3x/day) (View Repalyte Review and Repalyte Label ). Patient was hospitalized.

5877221-4 | Cytolytic Hepatitis
on Aug 29, 2008 Female patient from FRANCE , weighting 158.7 lb, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Celsentri (View Usage). Patient had the following side effects: cytolytic hepatitis. Celsentri dosage: . During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), KALETRA (View Kaletra Review and Kaletra Label ), COMBIVIR (View Combivir Review and Combivir Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ).

5703339-2 | No Adverse Event
on Mar 27, 2008 Male patient from UNITED KINGDOM , 39 years of age, was treated with Celsentri (View Usage). After Celsentri was administered, patient had the following side effects: no adverse event. Celsentri dosage: .

5698186-4 | Treatment Failure
Patient was taking Celsentri (View Usage). Patient experienced the following unwanted or unexpected effects: treatment failure on Mar 27, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, . Celsentri dosage: .

5676424-1 | Treatment Failure
Adverse event was reported on Mar 12, 2008 by a Male patient taking Celsentri (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 39 years of age, Patient had the following side effects: treatment failure.